Contact : 407-497-1484
Navigate compliance with tailored strategies and insights.
Navigate compliance with tailored strategies and insights.
Norita Persaud is a pharmaceutical compliance expert with 20 years of investigative, criminal, regulatory, and compliance experience, including 13 years with the U.S. Drug Enforcement Administration (DEA). She specializes in controlled substance regulations, pharmaceutical diversion prevention, and compliance with the Controlled Substances Act (CSA) and the Chemical Diversion and Trafficking Act (CDTA).
Ms. Persaud began her DEA career as a Diversion Investigator, leading complex regulatory and investigative cases in Mississippi and Florida. Her work resulted in numerous criminal convictions, civil fines, and administrative actions, earning her multiple performance awards, including the 2016 Mississippi Top Cop Award.
She later advanced to Supervisory Diversion Investigator in Los Angeles, California, where she led a specialized investigative group at the Southern California High Intensity Drug Trafficking Area (HIDTA). Under her leadership, investigators seized thousands of dosage units of controlled substances and over $3 million in illicit assets. She also provided training and lectures to federal, state, and local officials, regulatory boards, universities, and DEA registrants.
Ms. Persaud was then selected for a prestigious overseas Supervisory Diversion Investigator position in Bogotá, Colombia, overseeing controlled substance and precursor chemical enforcement for Colombia, Ecuador, and Venezuela. She collaborated with the Colombian National Policeand the Ministry of Justice, leading investigations that resulted in record precursor chemical seizures and regulatory reforms. Her expertise contributed to strengthening Colombia’s precursor chemical laws and enhancing international cooperation on chemical trafficking.
A respected mentor, trainer, and speaker, Ms. Persaud has educated law enforcement agencies, industry professionals, and regulatory bodies on pharmaceutical compliance and drug diversion.
Currently, she is the founder and principal consultant of her own pharmaceutical compliance firm, advising DEA registrants, manufacturers, distributors, pharmacies, and attorneys on complex federal and state regulations. She specializes in compliance strategies, risk mitigation, and regulatory guidance to ensure adherence to controlled substance laws.
At Aces Regulatory Consulting, we provide nationwide representation for healthcare providers in all DEA-related matters. Our services cover registration denials, renewals, and surrenders, as well as audits, inspections, investigations, and federal prosecutions. While DEA compliance should be a routine process, even minor errors or seemingly harmless questions can lead to serious consequences. As DEA compliance consultants, our priority is to protect our clients from unwarranted federal action or penalties while delivering knowledgeable and efficient legal representation that safeguards their ability to practice medicine or operate their business.
Our healthcare fraud defense team includes attorneys with extensive experience in private healthcare law, along with high-level backgrounds in the DOJ. This unique combination allows us to assess DEA-related issues from multiple perspectives and develop comprehensive strategies that effectively address federal concerns.
DEA audits and inspections are a routine part of the healthcare industry, particularly in certain sectors, but that doesn’t mean providers can afford to take them lightly. If you or an employee has received a DEA Form 82 (Notice of Inspection of Controlled Premises) or an administrative inspection warrant, it is crucial to consult with an experienced defense attorney or a top DEA compliance consultant before granting access or providing any information. In most cases—when presented with a DEA Form 82—providers have the right to informed consent for DEA audits. It is essential to understand your rights and evaluate whether consenting is in your best interest.
During an audit or inspection, DEA agents may request patient and billing records, interview employees, and employ various methods to gather information. Given the potential risk that any disclosed information could be interpreted as evidence of a federal healthcare law violation or criminal offense, it is vital to make informed decisions from the outset of the audit or inspection process.
DEA audits, inspections, and investigations can lead to criminal charges under a wide range of federal statutes, including:
In many cases, a DEA investigation can be either civil or criminal in nature. If federal prosecutors have not yet filed criminal charges, our top priority is to keep the matter civil. However, if criminal charges—and the risk of federal imprisonment—become unavoidable, we act swiftly and strategically to mitigate the consequences of your DEA investigation. Whenever possible, we work to secure a favorable resolution before trial.
Our attorneys have extensive experience assisting clients with DEA registration and renewal, ensuring compliance with the requirements for submitting a successful DEA Form 224 (initial registration) or DEA Form 224a (renewal registration). While the process is expected to take four to six weeks, delays are common, and many providers go months without a response—only to later learn that their applications have been denied.
When the DEA denies a registration application, it must issue a show cause order, outlining the reasons for denial, which may include:
If you receive a show cause order, you have the right to request a hearing and challenge the denial of your DEA registration. Given the complexities and serious consequences involved, securing skilled federal defense representation is strongly recommended to protect your ability to practice or operate your business.
If the DEA has requested that you voluntarily surrender your registration, it is crucial to fully understand your legal rights. Most importantly, you are not required to surrender your registration at any point during a DEA audit or investigation.
Before making any decisions, you should also consider the potential consequences of voluntary surrender, which may include:
If a DEA agent has asked you to surrender your registration, we strongly recommend seeking legal guidance before taking any action. Contact us for a free and confidential consultation to discuss your options and protect your rights.
DEA registration suspensions and revocations can arise from various factors, making it essential for registrants to take informed and strategic action when facing a DEA inquiry. Our attorneys have extensive knowledge of what does—and does not—constitute grounds for suspension or revocation. If the DEA is attempting to suspend or revoke your registration, we can provide the legal guidance and defense necessary to protect your right to practice or operate your business.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.